At a confirmation hearing Wednesday, President Donald Trump’s pick for the director of Centers for Disease Control and Prevention, Dr. Susan Monarez, faced questions about her stance on vaccines — after Health and Human Services Secretary Robert F. Kennedy, Jr., a vaccine skeptic, has recently made controversial choices around them

Monarez was clear in her support for vaccines.

“I think vaccines save lives. I think that we need to continue to support the promotion of utilization of vaccines,” Monarez said.

Her comments came as she was asked by Independent Sen. Bernie Sanders about a recent decision reported by POLITICO that Kennedy has decided to end U.S. funding for a global vaccine alliance, Gavi.

“I wasn’t involved in that decision making. If I’m confirmed as a CDC director, I will certainly look into it, and I’m happy to follow up with you,” Monarez said.

Kennedy has long held many vaccine-skeptic views, refuted by experts and high-quality studies, long before he joined the administration, but he has insisted he is not “anti-vaccine” and rather “pro-safety.”

Earlier this month, Kennedy removed all 17 sitting members of the CDC’s vaccine advisory committee and replaced them with new members. The move has been controversial, with some experts saying it makes the U.S. “less prepared for infectious disease threats.”

Monarez also stood apart from Kennedy on her views on autism, and whether there is any link between the neurological disorder and childhood vaccinations — which Kennedy has long raised as a potential reason for rising rates of autism diagnoses.

“I have not seen a causal link between vaccines and autism,” Monarez said, asked by Sanders if she agrees with the American Medical Association’s stance “that there is no scientific proven link between vaccines and autism.”

Kennedy, in his own confirmation hearing, refused to acknowledge that there is not a link between vaccines and autism, causing him to nearly lose the key vote of Sen. Bill Cassidy, a Republican and a doctor.

Kennedy has since launched a major effort at NIH to look into the causes of rising autism diagnoses.

The myth that vaccines cause autism was born out of a fraudulent 1998 study, hypothesizing that the measles, mumps, rubella vaccine caused intestinal inflammation, which, in turn, led to the development of autism.

The paper has since been discredited by health experts, retracted from the journal in which it was published, and its primary author, Andrew Wakefield, lost his medical license after an investigation found he had acted “dishonestly and irresponsibly” in conducting his research.

More than a dozen high-quality studies have since found no evidence of a link between childhood vaccines and autism.

Monarez outlined her credentials in her opening statements, touting her experience with health technology and public health. She also laid out her goals as the CDC director, which includes restoring public trust, modernizing public health infrastructure and employing evidence-based rapid decision making.

“These priorities support the president’s and the secretary’s vision of a healthier America. To achieve them, I will lead with integrity, transparency and purpose, and work with Congress to maximize health outcomes and protect the American people,” Monarez said in her opening statement.

Trump tapped Monarez to lead the CDC in March after the administration withdrew Trump’s other pick, Dr. David Weldon, to head the agency citing the fact that he did not have the votes needed to be confirmed.

Monarez, if confirmed, will work with Kennedey to “prioritize Accountability, High Standards, and Disease Prevention to finally address the Chronic Disease Epidemic and, MAKE AMERICA HEALTHY AGAIN!” Trump said in a social media post announcing her nomination.

Monarez has served as the acting CDC director since late January.

She has experience in both the public and private sector — including working in the government under former presidents George W. Bush, Barack Obama, Trump’s first term and Joe Biden. Her work has included strategies to combat antimicrobial resistance, too.

She has also led projects to use artificial intelligence and machine learning to improve health outcomes.